- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06756165
- Original Trial
Community Based Mental Health Screening and Referral (MeSH)
Community-Based Mental Health Screening & Referral for Flood-Affected Women in Dadu: A Feasibility Study
Study Overview
Status
Intervention / Treatment
Detailed Description
This study evaluates the feasibility and implementation of a community-based mental health screening, referral, and resilience-building intervention for women of reproductive age (WRA) affected by the 2022 floods in the Dadu district of Sindh, Pakistan. The intervention engages Lady Health Workers (LHWs) to screen WRA using validated tools-GAD-2 and PHQ-2. Women scoring ≥3 on either scale will be referred to Basic Health Units (BHUs), where trained facility-based doctors will reassess them using the GAD-7 and PHQ-9 instruments. Based on the diagnosis, WRA with mild to moderate symptoms will receive two structured counseling sessions, while those with severe symptoms will be referred to tertiary care with logistical support.
In parallel, LHWs will conduct monthly group sessions to raise mental health awareness, address stigma, and build community resilience to climate change-related hazards such as flooding. These sessions, based on a standardized curriculum, are open to all WRA regardless of screening status and focus on stress management, coping strategies, and emotional support.
The study employs a quasi-experimental design with a comparison group across selected union councils. The intervention will be evaluated through baseline and end-line quantitative surveys as well as qualitative assessments via focus group discussions (FGDs) and in-depth interviews (IDIs). The primary outcomes include feasibility, acceptability, appropriateness, and awareness levels, while the secondary outcome assesses the effectiveness of the intervention in reducing symptoms of depression and anxiety.
The findings will guide future efforts to integrate mental health services into primary care and community-based disaster preparedness strategies in Pakistan and similar contexts.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Sinddh
-
Karachi, Sinddh, Pakistan, 75300
- Aga Khan University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women of reproductive age (WRA) 18-49 years in the targeted area
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Arm
This arm focuses on enhancing mental health through structured activities integrated into existing community and primary health services.
Participants in this arm will receive additional support to address mental health challenges within the flood-affected communities of Dadu.
The intervention leverages trained Lady Health Workers (LHWs) and healthcare staff at primary health centers to screen, manage and provide timely referrals.
|
Participants in the intervention arm will receive a mental health screening, referral, and counselling program by trained LHWs and BHU staff.
LHWs will screen 120-170 WRA using PHQ-2 and GAD-2.
Screen-positive WRA will be referred to BHUs, where trained doctors will reassess them using PHQ-9 and GAD-7.
Those with mild to moderate anxiety or mild to moderately severe depression will receive two counselling sessions (initial and follow-up), each lasting at least 20 minutes, covering psychoeducation, awareness, and coping strategies.
Severe cases will be referred to tertiary care for specialized mental health services.
Mild cases will be advised to join resilience-building sessions.
All WRA will attend two of three monthly group sessions by LHWs (20-25 WRA, 2 hours each), focusing on mental health literacy and coping strategies, including those related to climate change stressors like floods.
|
|
No Intervention: Control Arm
Participants in the control arm will receive the standard care currently provided in the study area, which includes routine health services delivered by community health workers and the healthcare system.
The control arm serves as a comparison group, enabling an evaluation of the additional impact of the intervention on mental health outcomes, resilience, and community engagement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of Intervention
Time Frame: Data will be collected at baseline and approximately 12 months after the intervention begins.
|
A structured questionnaire will be used to assess the feasibility of implementing the community-based mental health screening, referral, and resilience-building intervention. It will be administered to Lady Health Workers (LHWs), health facility staff, and program implementers. The tool will assess recruitment success, retention rates, adherence to protocol, and challenges encountered during implementation. Measurement Tool: A specifically designed feasibility assessment questionnaire. |
Data will be collected at baseline and approximately 12 months after the intervention begins.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety Symptoms
Time Frame: Assessed at baseline and 12 months after intervention initiation.
|
Anxiety symptoms will be measured using the Generalized Anxiety Disorder-7 (GAD-7), a validated screening tool. Scores range from 0 to 21, with higher scores indicating more severe anxiety symptoms. Measurement Tool: GAD-7 questionnaire. |
Assessed at baseline and 12 months after intervention initiation.
|
|
Depression Symptoms
Time Frame: Assessed at baseline and 12 months after intervention initiation..
|
Depression symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9), a standardized and validated tool. Scores range from 0 to 27, with higher scores reflecting greater severity. Measurement Tool: PHQ-9 questionnaire. |
Assessed at baseline and 12 months after intervention initiation..
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-10475-30776
- 53600 (Other Grant/Funding Number: Grand Challenges Canada)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Bekelu Teka WorkuJimma UniversityNot yet recruitingPrenatal Depression | Mental Health Related Quality of Life | Maternal Postpartum Depression | Paternal Postpartum DepressionEthiopia
Clinical Trials on Mental health screening
-
University of Maryland, BaltimoreUniversity of UtahCompletedMental Health Wellness 1United States
-
University Hospital of North NorwayUniversity of TromsoCompleted
-
Kenyatta National HospitalNational Institute of Mental Health (NIMH)RecruitingDepression, Anxiety | Antenatal Depression | Postnatal DepressionKenya
-
University of ChicagoNational Institute of Mental Health (NIMH)RecruitingChild Behavior Problem | Mental Health | Child Externalizing ProblemsAzerbaijan
-
Cedars-Sinai Medical CenterMaternal Mental Health NOWActive, not recruitingDepression | Inflammation | Vitamin D Deficiency | Pre-EclampsiaUnited States
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceNot yet recruiting
-
University of OxfordNational Institute of Mental Health and Neuro Sciences, India; Dr. Rajendra...RecruitingDepression | PTSD | Anxiety | Suicidal Ideation | SomatizationIndia
-
McMaster UniversityHamilton Health Sciences Corporation; Ontario Mental Health Foundation; St. Joseph...CompletedMental Health ImpairmentCanada
-
Ana Catarina Navarro RamalhoActive, not recruitingDepression | Anxiety | Chronic Musculoskeletal PainBelgium
-
National University of MalaysiaNot yet recruitingResilience | Depression - Major Depressive DisorderMalaysia